JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kwon, G.
Right arrow Articles by McDaniel, M. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kwon, G.
Right arrow Articles by McDaniel, M. L.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

J Biol Chem, Vol. 274, Issue 26, 18702-18708, June 25, 1999

Tumor Necrosis Factor alpha -induced Pancreatic beta -Cell Insulin Resistance Is Mediated by Nitric Oxide and Prevented by 15-Deoxy-Delta 12,14-prostaglandin J2 and Aminoguanidine
A ROLE FOR PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR gamma  ACTIVATION AND iNOS EXPRESSION

Guim Kwon, Guang Xu, Connie A. Marshall, and Michael L. McDaniel

From the Department of Pathology, Washington University School of Medicine, St. Louis, Missouri 63110

Recent studies have identified a beta -cell insulin receptor that functions in the regulation of protein translation and mitogenic signaling similar to that described for insulin-sensitive cells. These findings have raised the novel possibility that beta -cells may exhibit insulin resistance similar to skeletal muscle, liver, and fat. To test this hypothesis, the effects of tumor necrosis factor-alpha (TNFalpha ), a cytokine proposed to mediate insulin resistance by interfering with insulin signaling at the level of the insulin receptor and its substrates, was evaluated. TNFalpha inhibited p70s6k activation by glucose-stimulated beta -cells of the islets of Langerhans in a dose- and time-dependent manner, with maximal inhibition observed at ~20-50 ng/ml, detected after 24 and 48 h of exposure. Exogenous insulin failed to prevent TNFalpha -induced inhibition of p70s6k, suggesting a defect in the insulin signaling pathway. To further define mechanisms responsible for this inhibition and also to exclude cytokine-induced nitric oxide (NO) as a mediator, the ability of exogenous or endogenous insulin ± inhibitors of nitric-oxide synthase (NOS) activity, aminoguanidine or N-monomethyl-L-arginine, was evaluated. Unexpectedly, TNFalpha and also interleukin 1 (IL-1)-induced inhibition of p70s6k was completely prevented by inhibitors that block NO production. Western blot analysis verified inducible NOS (iNOS) expression after TNFalpha exposure. Furthermore, the ability of IL-1 receptor antagonist protein, IRAP, to block TNFalpha -induced inhibition of p70s6k indicated that activation of intra-islet macrophages and the release of IL-1 that induces iNOS expression in beta -cells was responsible for the inhibitory effects of TNFalpha . This mechanism was confirmed by the ability of the peroxisome proliferator-activated receptor-gamma agonist 15-deoxy-Delta 12,14-prostaglandin J2 to attenuate TNFalpha -induced insulin resistance by down-regulating iNOS expression and/or blocking IL-1 release from activated macrophages. Overall, TNFalpha -mediated insulin resistance in beta -cells is characterized by a global inhibition of metabolism mediated by NO differing from that proposed for this proinflammatory cytokine in insulin-sensitive cells.


Copyright © 1999 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Cardiovasc ResHome page
H.-R. Liu, L. Tao, E. Gao, Y. Qu, W. B. Lau, B. L. Lopez, T. A. Christopher, W. Koch, T.-L. Yue, and X.-L. Ma
Rosiglitazone inhibits hypercholesterolaemia-induced myeloperoxidase upregulation--a novel mechanism for the cardioprotective effects of PPAR agonists
Cardiovasc Res, December 4, 2008; (2008) cvn308v2.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
R. Weiss, A. M. Cali, J. Dziura, T. S. Burgert, W. V. Tamborlane, and S. Caprio
Degree of Obesity and Glucose Allostasis Are Major Effectors of Glucose Tolerance Dynamics in Obese Youth
Diabetes Care, July 1, 2007; 30(7): 1845 - 1850.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
M. Pietropaolo, E. Barinas-Mitchell, and L. H. Kuller
The Heterogeneity of Diabetes: Unraveling a Dispute: Is Systemic Inflammation Related to Islet Autoimmunity?
Diabetes, May 1, 2007; 56(5): 1189 - 1197.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
M. A. Carvalho-Filho, M. Ueno, S. M. Hirabara, A. B. Seabra, J. B.C. Carvalheira, M. G. de Oliveira, L. A. Velloso, R. Curi, and M. J.A. Saad
S-Nitrosation of the Insulin Receptor, Insulin Receptor Substrate 1, and Protein Kinase B/Akt: A Novel Mechanism of Insulin Resistance
Diabetes, April 1, 2005; 54(4): 959 - 967.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
B. Emanuelli, M. Glondu, C. Filloux, P. Peraldi, and E. Van Obberghen
The Potential Role of SOCS-3 in the Interleukin-1{beta}-Induced Desensitization of Insulin Signaling in Pancreatic Beta-Cells
Diabetes, December 1, 2004; 53(suppl_3): S97 - S103.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
F. J. Sanchez-Gomez, E. Cernuda-Morollon, K. Stamatakis, and D. Perez-Sala
Protein Thiol Modification by 15-deoxy-{Delta}12,14-Prostaglandin J2 Addition in Mesangial Cells: Role in the Inhibition of Pro-inflammatory Genes
Mol. Pharmacol., November 1, 2004; 66(5): 1349 - 1358.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
G. Pilon, P. Dallaire, and A. Marette
Inhibition of Inducible Nitric-oxide Synthase by Activators of AMP-activated Protein Kinase: A NEW MECHANISM OF ACTION OF INSULIN-SENSITIZING DRUGS
J. Biol. Chem., May 14, 2004; 279(20): 20767 - 20774.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
H. Li, L. Groop, A. Nilsson, J. Weng, and T. Tuomi
A Combination of Human Leukocyte Antigen DQB1*02 and the Tumor Necrosis Factor {alpha} Promoter G308A Polymorphism Predisposes to an Insulin-Deficient Phenotype in Patients with Type 2 Diabetes
J. Clin. Endocrinol. Metab., June 1, 2003; 88(6): 2767 - 2774.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P. D. Borge Jr. and B. A. Wolf
Insulin Receptor Substrate 1 Regulation of Sarco-endoplasmic Reticulum Calcium ATPase 3 in Insulin-secreting beta -Cells
J. Biol. Chem., March 21, 2003; 278(13): 11359 - 11368.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
C. J. Barker, I. B. Leibiger, B. Leibiger, and P.-O. Berggren
Phosphorylated inositol compounds in beta -cell stimulus-response coupling
Am J Physiol Endocrinol Metab, December 1, 2002; 283(6): E1113 - E1122.
[Abstract] [Full Text] [PDF]


Home page
Hum Exp ToxicolHome page
J D Tugwood and C T Montague
Biology and toxicology of PPARg ligands
Human and Experimental Toxicology, August 1, 2002; 21(8): 429 - 437.
[Abstract] [PDF]


Home page
J. Leukoc. Biol.Home page
M. Aga, C. J. Johnson, A. P. Hart, A. G. Guadarrama, M. Suresh, J. Svaren, P. J. Bertics, and B. J. Darien
Modulation of monocyte signaling and pore formation in response to agonists of the nucleotide receptor P2X7
J. Leukoc. Biol., July 1, 2002; 72(1): 222 - 232.
[Abstract] [Full Text] [PDF]


Home page
British Journal of Diabetes & Vascular DiseaseHome page
L. S. Hermann and N. Wiernsperger
Impaired glucose tolerance and metformin: clinical and mechanistic aspects
The British Journal of Diabetes & Vascular Disease, May 1, 2002; 2(3): 177 - 183.
[Abstract] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
H. Sugita, M. Kaneki, E. Tokunaga, M. Sugita, C. Koike, S. Yasuhara, R. G. Tompkins, and J. A. J. Martyn
Inducible nitric oxide synthase plays a role in LPS-induced hyperglycemia and insulin resistance
Am J Physiol Endocrinol Metab, February 1, 2002; 282(2): E386 - E394.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
N. Stefan, A. Fritsche, H. Häring, and M. Stumvoll
Effect of Experimental Elevation of Free Fatty Acids on Insulin Secretion and Insulin Sensitivity in Healthy Carriers of the Pro12Ala Polymorphism of the Peroxisome Proliferator-Activated Receptor-{gamma}2 Gene
Diabetes, May 1, 2001; 50(5): 1143 - 1148.
[Abstract] [Full Text]


Home page
FASEB J.Home page
A. VON KNETHEN and B. BRUNE
Delayed activation of PPAR{gamma} by LPS and IFN-{gamma} attenuates the oxidative burst in macrophages
FASEB J, February 1, 2001; 15(2): 535 - 544.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
W. S. Cruz, G. Kwon, C. A. Marshall, M. L. McDaniel, and C. F. Semenkovich
Glucose and Insulin Stimulate Heparin-releasable Lipoprotein Lipase Activity in Mouse Islets and INS-1 Cells. A POTENTIAL LINK BETWEEN INSULIN RESISTANCE AND beta -CELL DYSFUNCTION
J. Biol. Chem., April 6, 2001; 276(15): 12162 - 12168.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 1999 by the American Society for Biochemistry and Molecular Biology.